The state of New York will provide up to $188 million to help establish a new comprehensive cancer center in the Queens borough of New York City.

TG Therapeutics said it is working to develop a subcutaneous (under-the-skin) version of relapsing MS therapy Briumvi.

Sales of the Lush Roots Scalp Treatment have soared by over 264% YOY, here's why it's so important to your scalp care routine ...

Levetiracetam in Sodium Chloride Injection is an antiepileptic drug indicated for adjunctive therapy i) in the treatment of partial-onset seizures in adults with epilepsy, ii) in the treatment of ...

Early postmenopausal women who receive zoledronate every 5 years have a lower risk for morphometric vertebral fractures than ...

The FDA is reviewing new vaccines for meningitis and chikungunya and therapies for Parkinson disease and PTSD.

Autolus Therapeutics plc (Nasdaq: AUTL), a commercial-stage biopharmaceutical company developing, manufacturing and delivering next-generation programmed T cell therapies, announces an oral ...

Celebrities like Chrissy Teigen and Matthew Perry have been open about using ketamine for their mental health – here's what ...

This insightful interactive webinar delves into the motor and non-motor symptoms experienced by patients with Parkinson’s ...

Oncology nurses can educate patients on the benefits of subcutaneous administration, including reduced time in the infusion ...

Women in early menopause receiving two infusions of zoledronate 5 years apart show a significantly lower risk for fracture at ...

Life-changing gene therapies for hemophilia have become available, yet many patients and providers have not yet rushed to try ...